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Lipoxin A4 inhibits TNF-a–induced production of interleukins
and proliferation of rat mesangial cells.
Background. Studies have shown that lipoxin A4 (LXA4)
and its analogues inhibited proliferation of glomerular mesan-
gial cells induced by leukotriene D4 (LTD4) or platelet-derived
growth factor (PDGF), reduced the production of proinflam-
matory cytokines such as interleukin (IL)-1b and IL-6 in
renal tissue of ischemic injury. In the present studies, we ex-
amine whether LXA4 have inhibitory effects on tumor necrosis
factor-a (TNF-a)–induced productions of IL-1b and IL-6 and
proliferation of glomerular mesangial cells of rat, and explore
the molecular mechanisms of signal pathway of LXA4.
Methods. Cultured glomerular mesangial cells were treated
with TNF-a (10 ng/mL), with or without preincubation with
LXA4 at the different concentrations. Cell proliferation was
assessed by [3H]-thymidine incorporation. Proteins of IL-1b
and IL-6 in supernatant were analyzed by enzyme-linked im-
munosorbent assay (ELISA). Expressions of mRNA of IL-1b
and IL-6 were determined by real-time polymerase chain re-
action (PCR) and cyclin E by reverse transcription (RT)-PCR.
Proteins of cyclin E, threonine phosphorylated Akt1 at 308 site
(Thr308) and p27kip1 were analyzed by Western blotting studies.
Activities of signal transducers and activators of transcription-
3 (STAT3), nuclear factor-jB (NF-jB) were determined by
electrophroretic mobility shift assay (EMSA). Expression of
Src homology (SH) 2–containing protein-tyrosine phosphatase
(SHP-2) was assessed by immunoprecipitation and im-
munoblotting.
Results. TNF-a–stimulated proliferation, release of proteins
and expressions of mRNA of IL-1b and IL-6 in mesangial cells
were inhibited by LXA4 in a dose-dependent manner. The
marked increments in mRNA expression and protein synthesis
of cyclin E induced by TNF-a in parallel with proliferation of
mesangial cells were down-regulated by LXA4. LXA4 antago-
nized the phosphorylation of SHP-2 and activity of NF-jB in-
duced by TNF-a. Pretreatment of the cells with NF-jB inhibitor
pyrrolidine dithio-carbamate (PDTC) blocked the productions
of IL-1b , IL-6, and activation of NF-jB induced by TNF-a.
Stimulation of mesangial cells with TNF-a resulted in enhanced
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DNA-binding activity of STAT3. This increment was inhibited
by LXA4 in a dose-dependent manner. Threonine phosphory-
lated Akt1 protein at 308 site stimulated by TNF-a was reduced
by LXA4. TNF-a–induced decrement in expression of p27kip1
protein was ameliorated by LXA4 in a dose-dependent manner.
Conclusion. TNF-a–induced proliferation and increment of
cyclin E of rat mesangial cells can be inhibited by LXA4, and
these inhibitory effects might be through the mechanisms of
STAT3 and Akt1/p27kip1 pathway-dependent signal transduc-
tion. LXA4 also antagonized TNF-a–stimulated IL-1b and IL-
6 synthesis, and these antagonisms were related to SHP-2 and
NF-jB pathway-dependent signal transduction.
Leukotrienes and lipoxins are eicosanoids which are
generated via biochemical pathways catalyzed by lipoxy-
genase enzymes. Leukotrienes are potent proinflamma-
tory compounds during glomerular inflammatory event.
In this setting, they have been implicated as triggers for
intrarenal vasoconstriction, mesangial cell contraction,
and proliferation of resident glomerular cells as previ-
ously demonstrated by our and others’ investigations
[1–4]. Lipoxins antagonized many responses evoked by
leukotrienes and act as endogenous “braking signals” in
the inflammatory process [1, 5, 6]. Lipoxin A4 (LXA4)
opposed the vasoconstrictor property of leukotriene D4
(LTD4) and ameliorated LTD4-triggered decrements in
renal blood flow (RBF) and glomerular filtration rate
(GFR) [1] and also antagonized the mitogenic effect
of LTD4 on human mesangial cells [7]. Moreover, sev-
eral reports indicated that lipoxins also modulated cell
responses to cytokines besides leukotrienes. LXA4 in-
hibited tumor necrosis factor-a (TNF-a)–initiated inter-
leukin (IL)-1b production by neutrophils [8], attenuated
TNF-a–stimulated IL-8 and monocyte chemoattractant
protein-1 (MCP-1) release by colonic cell lines [9, 10],
antagonized IL-1b–induced production of IL-6, IL-8, and
matrix metalloproteinase-3 (MMP-3) in synovial fibrob-
lasts [11], inhibited proliferation of mesangial cells ac-
tivated by platelet-derived growth factor (PDGF) [12].
Recently, Kieran et al [13] and Leonard et al [14] demon-
strated that LXA4 analogues inhibited renal synthesis of
IL-1b and IL-6 in experimental ischemic renal injury. It is
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well known that TNF-a plays a pivotal role in activation
of mesangial cells during glomerular inflammation [15–
19]. However, it remains unclear whether lipoxins inhibit
the proliferation of mesangial cells induced by TNF-a,
and whether lipoxins inhibit the production of cytokines
by mesangial cells, and no definitive reports implicate
the mechanism by which LXA4 antagonizes the mito-
genic and proinflammatory effects of TNF-a on mesan-
gial cells. The present studies were therefore undertaken
to find whether LXA4 inhibited synthesis of IL-1b and
IL-6, and cell growth induced by TNF-a in rat mesangial
cells.
The mitogenic and proinflammatory effects of TNF-a
on mesangial cells have been documented by other in-
vestigators [16–19]. The biologic actions of TNF-a are
mediated by two cell surface receptors, TNFR-1 and
TNFR-2. TNF-a exerts its biologic effects through the
Janus-activated kinase-1 (JAK1)/signal transducers and
activators of transcription (STAT) signal pathway and
such signals are initiated through an interaction between
TNFR-1 and JAK1 in human B cells [20]. STAT pro-
teins are latent transcription factors and activation of
STAT proteins is often associated with differentiation and
growth regulation [21]. STAT3 is a member of the STAT
protein family and a key signaling molecule in mesan-
gial cell proliferation mediated by autocrine growth fac-
tor Gas6 in vitro and in vivo [22]. In the present studies,
we determine whether LXA4 inhibits TNF-a–activated
JAK1/STAT3 signaling in mesangial cells.
LXA4 stimulation of mitogen activated protein kinase
(MAPK) superfamily such as p38 and erk involves two
distinct receptors on membrane of human renal mesan-
gial cells: one named cysLT1/LTD4 receptor, shared with
LTD4 and coupled to pertussis toxin (PTX)-sensitive G
protein, and another named myeloid LXA4 receptor and
coupled via a PTX-insensitive alternative G protein to
erk activation [7]. Stimulation of this receptor by LXA4
results in sustained erk activation which is associated
with extroproliferative effects of erk, such as an expres-
sion of cyclin-dependent kinase (CDK) inhibitor pro-
tein and inhibition of DNA synthesis [7]. CDK inhibitors
include p27kip1, a potential mediator of extracellular
antimitogenic signals. p27kip1 causes G1 arrest by inhibit-
ing the activity of cyclin E/CDK2. Several mitogenic fac-
tors are known to decrease p27kip1 protein amounts upon
transition from the G1 to S phase of the cell cycle [23].
p27kip1 protein was important in determining the mesan-
gial cell’s proliferative responses to PDGF and basic fi-
broblast growth factor (bFGF) in vitro [24]. Akt is protein
kinase B (PKB) and known to down-regulate p27kip1 tran-
scription by phosphorylation-dependent inhibition of the
Forkhead family of transcription factors [25]. Akt phos-
phorylates p27kip1 at Thr187 and promotes p27kip1 desta-
bilization. Akt also promotes 14-3-3 protein binding to
p27kip1 by phosphorylation at Thr198, allowing its cyto-
plasmic localization and degradation [23]. In the current
studies, we assess whether TNF-a alters expression of cy-
clin E and Akt1/p27kip1 in parallel with the cell growth
stimulated by TNF-a, and explore whether these alter-
ation could be modulated by LXA4 in mesangial cells.
Upon TNF-a stimulation, nuclear factor-jB (NF-jB)
plays a central role in mesangial cell activation [26].
NF-jB is normally inactive in the cytoplasm and non-
covalently complexed with a cytoplasmic inhibitor of
jB (IjB). After IjBs are phosphorylated by IjB ki-
nase (IKK) and dissociated from IjB–NF-jB complex,
NF-jB dimers enter the nucleus and activate a series
of genes. NK-jB–inducing kinase (NIK) is upstream ki-
nase of IKK [27]. TNF-a activates NIK through activa-
tion of ceramide-activated protein kinase (CAPK) and
TNF receptor–associated factor (TRAF) [28, 29]. Src ho-
mology (SH) 2–containing protein-tyrosine phosphatase
(SHP-2) is an integral component of the IKK complex
and a functional SHP-2 is required for efficient phospho-
rylation of IjB by the IKK complex in cellular response
to TNF-a [30]. SHP-2 plays a positive role in mediating
the induction of NF-jB activity and IL-6 synthesis stimu-
lated by TNF-a [30]. It is supposed that TNF-a–activated
synthesis of IL-1b and IL-6 in mesangial cells is mediated
by SHP-2 and NF-jB signaling according to previous ob-
servations as mentioned above. The current studies there-
fore undertaken to determine whether LXA4 inhibits the
synthesis of IL-1b and IL-6 and activations of SHP-2 and
NF-jB signaling induced by TNF-a in mesangial cells.
METHODS
Culture of rat mesangial cells
Glomeruli were isolated from renal cortex of male
Sprague-Dawley rats weighing 100 to 150 g, purified by an
established mechanical differential sieving technique and
incubated with 1% collagenase type V (Sigma Chemical
Co., St. Louis, MO, USA) for 30 minutes at 37◦C. They
were subsequently evaluated for purity and counted by
microscopy through 25 lL aliquots of the glomerular iso-
lates. The purity of glomerular preparations was between
90% and 95%. Cultured mesangial cells were studied be-
tween passages 4 and 6 as to serial passages. The mesan-
gial cell monolayers were cultured in RPMI-1640 medium
(Gibco BRL, Grand Island, NY, USA), supplemented
with 20% fetal calf serum (FCS) (Sigma Chemical Co.),
penicillin (100 units/mL), streptomycin (100 lg/mL), and
insulin (5 lg/mL) at 37◦C in a 5% CO2 incubator after
trypsinization. These cells held the phenotypic charac-
teristics of mesangial cells, including stellate morphol-
ogy, desmin, vimentin, and Thy1.1 antigen expression, as
previously described [2]. Cell viability was measured by
trypan blue exclusion assay in pilot experiment and the
percentage of viable cells was more than 95% after ex-
posure to LXA4 (0.1 nmol/L, 1 nmol/L, and 10 nmol/L)
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(Sigma Chemical Co.) or TNF-a (10 ng/mL) (Sigma
Chemical Co.) for 24 hours.
Assessment of mesangial cell proliferation
Mesangial cells were seeded in 24-well plates (5×104
cells/well), cultured in RPMI-1640 medium containing
20% FCS and allowed to reach confluence. Prior to the
experiments, the mesangial cells were growth-arrested by
incubation for 48 hours with RPMI-1640 medium con-
taining 0.5% FCS. Subsequently, the cells were pretreated
with or without LXA4 at the concentrations of 0.1, 1,
and 10 nmol/L for 30 minutes and coincubation was con-
tinued for 24 hours with TNF-a (10 ng/mL). Control
cells were only incubated with RPMI-1640 medium con-
taining 0.5% FCS. Synthesis of DNA in mesangial cell
outgrowths was determined by incorporation of [3H]-
thymidine [2]. A pulse of 1 lCi of [3H]-thymidine (84.8
Ci/mmol) (New England Nuclear, Boston, MA, USA)
was added to each well for the final 4 hours of TNF-a
stimulation. Subsequently, the cells were washed three
times with cold phosphate-buffered saline (PBS), solu-
bilized in 1% sodium dodecyl sulfate (SDS), and pre-
cipitated by 10% trichloroacetic acid (TCA) for 30 min-
utes at 4◦C. TCA-precipitable material was then pelleted
by centrifugation and redissolved in NaOH (0.2 mol/L).
Beta radioactivity was measured in a liquid scintilla-
tion counter (Beckman LS 7500; Beckman Instruments,
Fullerton, CA, USA). The concentrations of the cell pro-
tein were determined by the method of Bradford (Sigma
Chemical Co.). Mean values obtained from 6 wells were
expressed as counts per minute (cpm)/lg protein.
Enzyme-linked immunosorbent assay (ELISA)
of IL-1b and IL-6 proteins
Growth-arrested mesangial cells were exposed to
RPMI-1640 medium with 0.5% FCS and TNF-a (10 ng/
mL) for 24 hours with or without preincubation with
LXA4 as mentioned above. Control cells were treated as
mentioned above. Supernatants were collected for mea-
surement of IL-1b and IL-6 proteins using ELISA kits
(Pierce Chemical Co., Rockford, IL, USA) following the
manufacturer’s instructions. The limits of detection for
IL-1b and IL-6 by the ELISA are 1 pg/mL. To explore
whether NF-jB activation play a role in production of IL-
1b and IL-6 induced by TNF-a, the cells were pretreated
with 0.1 mmol/L of potent NF-jB inhibitor pyrrolidine
dithio-carbamate (PDTC) (Sigma Chemical Co.) for 60
minutes before the exposure to TNF-a [31].
Real-time polymerase chain reaction (PCR) analysis
of IL-1b and IL-6 mRNA expression
Serum-starved mesangial cells were exposed to RPMI-
1640 with 0.5% FCS and TNF-a (10 ng/mL) for 12 hours
with or without preincubation with LXA4 as mentioned
above. Control cells were treated as mentioned above.
Cells were collected and total RNA extraction was per-
formed using Trizol reagent (Gibco BRL) followed by
chloroform-isopropanol extraction and ethanol precip-
itation. For real-time PCR (TaqMan-PCR), chromoso-
mal DNA was removed from total RNA using DNAse
I. The 2 lg of DNAse-treated RNA was reverse tran-
scribed to cDNA using the reverse transcription (RT)
system [Moloney-murine leukemia virus-reverse tran-
scription (M-MLV-RT)] (Promega, Madison, WI, USA).
Real-time PCR was performed on a TaqMan ABI 5700
Sequence Detection System (Applied Biosystems, Fos-
ter City, CA, USA) using heat-activated TaqDNA PCR
(Promega). Primers and TaqMan probes were designed
with Primer Premier 5.0 Software. The dual fluorescein-
labeled probe was 5′-labeled with FAM and 3′-labeled
with BH1. Commercially available predeveloped Taq-
Man assay reagents were used for the internal stan-
dards rat glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). The following sets of primers and probes
were used: for rat IL-1b , 5′-AGGCAGTGTCACTCA
TTGTGG-3′ (sense), 5′-TAGCAGGTCGTCATCATC
CC-3′ (antisense), and 5′-GGCAGCTACCTATGTCT
TGC-3′ (probe), amplifying a 155 bp fragment; for rat
IL-6, 5′-ACAGCCACTGCCTTCCCTAC-3′ (sense), 5′-
TCTCATTTCCAAGATCTCCC-3′ (antisense), and 5′-
CACAGAGGATACCACCCACA-3′ (probe), ampli-
fying a 197 bp fragment; for GAPDH, 5′-CGGCAA
GTTCAATGGCACAG-3′ (sense) and 5′-GACGCCA
GTAGACTCCACGAC-3′ (antisense), and 5′-GAGA
ATGGGAAGCTGGTCATC-3′ (probe), amplifying a
145 bp fragment. Real-time PCR was conducted with four
replicates, each in a 50 lL TaqMan Universal PCR Mas-
ter Mix (Applied Biosystems), together with 200 nmol/L
primers and 200 nmol/L probes. PCR conditions were set-
tled as incubation at 95◦C for 4 minutes followed by 40 cy-
cles of 45 seconds at 95◦C, 45 seconds at 55◦C, 30 seconds
at 75◦C, and final extension at 72◦C for 5 minutes. The IL-
1b , IL-6, and GAPDH cDNA templates were quantified
by standard curves of diluted standard cDNA. Controls
consisting of ddH2O were negative in all runs. Expression
data of TaqMan-PCR analysis of IL-1b and IL-6 mRNA
were shown as ratio of copies to expression of GAPDH.
RT-PCR analysis of cyclin E mRNA expression
Quiescent mesangial cells were exposed to RPMI-
1640 medium with 0.5% FCS and TNF-a (10 ng/mL)
for 12 hours with or without preincubation with LXA4
as mentioned above. Control cells were treated as men-
tioned above. Cells were harvested and total RNA ex-
traction was performed using Trizol reagent (Gibco
BRL) followed by chloroform-isopropanol extraction
and ethanol precipitation. RNA purity (A260/A280 > 1.6)
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was checked by spectrophotometer of GeneQuant (Type
II) (Pharmacia Co., Sweden) and RNA integrity was
confirmed by visualization of 28-second and 18-second
bands on 1% agarose gel. Subsequently, 1 lg of RNA
was reverse transcribed using the M-MLV-RT system
(Promega). RT-PCR analysis was performed with the fol-
lowing sets of primers: for rat cyclin E, 5′-TCCTTAT
GGTGTCCTCGCT-3′ (sense) and 5′-CTTGTAGACC
CCTGCTGCT-3′ (antisense), amplifying a 493 bp frag-
ment. The b-actin was used as internal controls, 5′-GG
TCAGTCCATGCCATTAG-3′ (sense) and 5′-CCGGA
ATCACCCTGTTGCC-3′ (antisense) generating a 247
bp fragment. The sets of cyclin E and b-actin primers
had been selected by software-aided analysis (Primer
Premier 5.0). PCR reactions were performed in a 20 lL
mixture containing 10× PCR buffer, MgCl2 (1.5 mmol/
L), deoxynucleoside triphosphate (dNTP) (200 lmol/L)
(Promega). Amplification protocols for cyclin E and b-
actin consisted of 30 repetitive cycles of predenaturing at
95◦C for 5 minutes, denaturing at 94◦C for 30 seconds,
annealing at 58◦C for 40 seconds, extension at 72◦C for
10 seconds, and final extension at 72◦C for 7 minutes.
Amplified cDNA was separated by 3% agarose gel elec-
trophoresis and visualized with ethidium bromide. Semi-
quantitative analysis was performed by using UVP-gel
densitometry (Gene Co., San Gabriel, CA, USA). Arbi-
trary unit (AU) of cyclin E = (AcyclinE/Ab−actin) × 100%.
Western blot analysis of cyclin E, phosphorylated
Akt1(Thr308), and p27kip1
Serum-restricted mesangial cells were exposed to
RPMI-1640 medium with 0.5% FCS and TNF-a (10 ng/
mL) for 15 minutes (for Akt1 measurement) or 24
hours (for cyclin E and p27kip1 measurement) with or
without preincubation with LXA4 as mentioned above.
Control cells were treated as mentioned above. After
trypsinization, the mesangial cells were washed with
ice cold PBS at the concentration of 0.01 mol/L. The
lysates were harvested and proteins were extracted us-
ing Protein Extraction Kits (Active Motif Co., Cam-
bridge, MA, USA) according to the manufacturer’s in-
structions. The concentrations of total protein in lysates
were measured by the method of Bradford. The 10 lL
of lysates (40 lg of protein/well) were electrophoresed
on 10% SDS-polyacrylamide gel for 4 hours before
blotting onto polyvinylidene difluoride (PVDF) mem-
branes (Amersham, Arlington, IL, USA). Nonspecific
sites on the membranes were blocked with 5% non-
fat milk in Tris-buffered saline (TBS) for 1 hour. The
blots were incubated with primary rabbit antirat an-
tibodies against cyclin E at 1:1000 dilution, phospho-
rylated Akt1 (Thr308) or p27kip1 (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) at 1:2000 dilution.
Following the incubation with these antibodies for
1 hour at room temperature, the membranes were washed
with TBS and incubated for 1 hour with a horseradish
peroxidase–conjugated goat antirabbit IgG antibodies
(Santa Cruz Biotechnology) at 1:4000 final dilution.
After washing, the membranes were incubated with
an enhanced chemiluminance (ECL) reagent system
(Amersham) and subsequently exposed to Kodak
Biomax films (Eastman Kodak, Rochester, NY, USA).
Semiquantitative analysis was performed by using UVP-
gel densitometry (Gene Co.). AU = (AcyclinE/Ab−actin or
AAkt1/Ab−actin or Ap27kip1/Ab−actin) × 100%.
Immunoprecipitation and immunoblotting assay
of SHP-2
Serum-deprived mesangial cells were exposed to
RPMI-1640 medium with 0.5% FCS and TNF-a (10 ng/
mL) for 30 minutes with or without preincubation with
LXA4 as mentioned above. Control cells were treated
as mentioned above. Cells were collected and total pro-
teins were extracted using Protein Extraction Kit (Pierce
Co., Rockford, IL, USA) following the manufacturer’s in-
structions. The quantitative analysis of proteins was per-
formed by the method of Bradford. The 0.5 mg of lysates
was added to Tris buffer containing 50 mmol/L Tris (pH
7.5), 150 mmol/L NaCl, 0.05% NP-40, 1 mmol/L ethylene-
diaminetetraacetate (EDTA), 0.25% gelatin, and 0.02%
NaN3, and total volume was 0.5 mL. Subsequently, the
lysates were incubated with 1 lg of rabbit antirat phos-
photyrosine antibody (PY20) (Santa Cruz Biotechnol-
ogy) at 4◦C for 2 hours and precipitated by 20 lL of
protein A/G agarose (Santa Cruz Biotechnology) at 4◦C
overnight. The immunoprecipitates were then recovered
by centrifugation and washed three times with ice-cold
wash buffer. The immunoprecitated proteins were boiled
for 5 minutes with 20 lL of sample buffer and then
electrophoresed on SDS-polyacrylamide gel and trans-
fered to PVDF membranes (Amersham). The mem-
branes were subjected to immunoblotting with rabbit
antirat SHP-2 antibodies (1:1000 dilution) (Santa Cruz
Biotechnology). Following the incubation with these an-
tibodies overnight at 4◦C, the membranes were washed
and incubated for 1 hour with a horseradish peroxidase–
conjugated goat antirabbit IgG antibodies (Santa Cruz
Biotechnology) at 1:2000 final dilution. After washing,
membranes were incubated with an ECL reagent sys-
tem (Amersham) and subsequently exposed to Kodak
Biomax films (Eastman Kodak). Semiquantitative analy-
sis was performed by using UVP-gel densitometry (Gene
Co.). AU = (ASHP−2/Ab−actin) × 100%.
Electrophoretic mobility shift assay (EMSA) of STAT3
and NF-jB activities
Growth-arrested mesangial cells were exposed to
RPMI-1640 with 0.5% FCS and TNF-a (10ng/mL) for
1 hour with or without preincubation with LXA4 as
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mentioned above. Control cells were treated as men-
tioned above. The activations of STAT3 and NF-jB were
evaluated by assessing the abilities of the nuclear proteins
to form complexes with a specific DNA probe in EMSA
[32]. Nuclear protein was extracted using Nuclear Protein
Extraction Kit (Active Motif Co.). EMSA was performed
by using Gel Shift Assay Kit (Promega) following the
manufacturer’s instructions. The 2 lL of nuclear extracts
containing 30 lg of total proteins was preincubated with 2
lL of gel shift binding 5× buffer for 10 minutes, followed
by the addition of 1 lL of c-[32P]-labeled double-stranded
oligonucleotide probes of STAT3 or NF-jB (Santa Cruz
Bioechnology) and further incubation for 20 minutes at
room temperature. The oligonucleotide pairs of STAT3
were 5′-GATCCTTCTGGGAATTCCTAGATC-3′ and
5′-GATCTAGGAATTCCCAGAAGGATC-3′, and of
NF-jB were 5′-AGTTGAGGGGACTTTCCCAGGC-3′
and 5′-GCCTGGGAAAGTCCCCTCAACT-3′, and ra-
diolabeled with c-[32P] adenosine triphosphate (ATP)
(Promega) by incubation with 10 units of T4 polynu-
cleotide kinase (Promega). Resulting nuclear protein-
DNA complexes were resolved in 4% nondenaturing
polyacrylamide gels (acrylamide:bisacrylamide = 60:1)
in 0.5× Tris borate EDTA buffer. Electrophoresis was
performed under 90 volts for 2 hours. Gels were dried
and exposed to Kodak Biomax films (Eastman Kodak)
at −70◦C for 36 hours. Semiquantitative analysis was
performed by using UVP-gel densitometry (Gene Co.).
AU = (A TNF−aor/andLXA4/A0.5%FCS) × 100%. Gel su-
pershift assay was performed by incubation of nuclear
protein-DNA complexes with 2 lg (0.1 lg/lL) of rab-
bit antirat p65, p50 of NF-jB antibodies (Santa Cruz
Biotechnology) on ice for 30 minutes, other procedures
were the same as mentioned above. Some cells were pre-
treated with 0.1 mmol/L of potent NF-jB inhibitor PDTC
(Sigma Chemical Co.) for 60 minutes before exposure to
TNF-a.
Statistical analysis
Results are expressed as mean ± standard error of
the mean (SEM). Experimental data were analyzed us-
ing one-way analysis of variance (ANOVA) followed by
S-N-K test (Q test) by Statistical Package for Social Sci-
ences version 10.0 (SPSS, Chicago, IL, USA). Differ-
ences were considered to be statistically significant when
P value was less than 0.05.
RESULTS
Effect of LXA4 on TNF-a–stimulated proliferation
of mesangial cells
As shown in Figure 1, TNF-a–stimulated proliferation
of mesangial cells, assessed by incorporation of [3H]-
thymidine, was inhibited by LXA4 at the concentrations
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Fig. 1. Proliferation of mesangial cells assessed by incorporation of
[3H]-thymidine (TdR) and expressed as cpm/lg protein. Cultured and
serum-starved glomerular mesangial cells were treated with tumor
necrosis factor-a (TNF-a) (10 ng/mL) for 24 hours, with or without
preincubation with lipoxin A4 (LXA4) at the indicated concentrations.
TNF-a–stimulated proliferation of mesangial cells was inhibited by
LXA4 in a dose-dependant manner. Data were mean ± SEM of six
independent experiments. ∗P < 0.05 compared to the cells treated with
TNF-a and 0.5% fetal calf serum (FCS) without LXA4. #P < 0.05 com-
pared to the cells treated with 0.5% FCS alone.
of 1 nmol/L and 10 nmol/L. LXA4 at the concentration of
0.1 nmol/L had no effect on TNF-a–stimulated prolifera-
tion of mesangial cells. Similar results were also obtained
by monotetrazolium (MTT) colorimetric assay (data not
shown). Incubation of rat mesangial cells with LXA4 (0.1,
1, and 10 nmol/L) alone had no significant role on pro-
liferation of quiescent rat mesangial cells, similar to the
reported by McMahon et al [7] who showed that LXA4 at
the concentration from 1 pmol/L to 1 lmol/L had no sig-
nificant effect on proliferation of human mesangial cells
cultured in 0.5% FCS. In pilot experiment, trypan blue
exclusion assay showed the percentage of viable cells was
more than 95% after exposure to LXA4 (0.1 nmol/L,
1 nmol/L, and 10 nmol/L) or TNF-a (10 ng/mL) for
24 hours.
Effect of LXA4 on TNF-a–induced IL-1b and
IL-6 expression
Expressions of IL-1b and IL-6 mRNA in mesangial
cells, assessed by real-time PCR, are shown in Figure 2.
Preincubation of mesangial cells with LXA4 (1 and 10
nmol/L) down-regulated the expressions of IL-1b and
IL-6 mRNA stimulated by TNF-a. Incubation of mesan-
gial cells with LXA4 (10 nmol/L) alone had no significant
role on IL-1b and IL-6 mRNA expressions. The results
of release of IL-1b and IL-6 protein in supernatants of
the cultured cells, determined by ELISA, are shown in
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Fig. 2. Real-time polymerase chain reaction (PCR) analysis of inter-
leukin (IL)-1b and IL-6 mRNA expression. Cultured and quiescent
mesangial cells were exposed to tumor necrosis factor-a (TNF-a) (10
ng/mL) for 12 hours with or without preincubation with lipoxin A4
(LXA4) at the indicated concentrations. Expression data of TaqMan-
PCR analysis of IL-1b and IL-6 mRNA are shown as ratio of copies to
expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Controls consisting of ddH2O were negative in all runs. Data were
mean ± SEM of four independent experiments. ∗P < 0.05 compared to
the cells treated with TNF-a and 0.5% fetal calf serum (FCS) without
LXA4. #P < 0.05 compared to the cells treated with 0.5% FCS alone.
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Fig. 3. Proteins of interleukin (IL)-1b and IL-6 assessed by enzyme-
linked immunosorbent assay (ELISA) in supernatant of cultured
mesangial cells. Cultured and serum-deprived glomerular mesangial
cells were treated with tumor necrosis factor-a (TNF-a) (10 ng/mL) for
24 hours, with or without preincubation with lipoxin A4 (LXA4) at the
indicated concentrations. TNF-a–stimulated release of IL-1b and IL-6
of mesangial cells were inhibited by LXA4 in a dose-dependant man-
ner. Nuclear factor-jB (NF-jB) inhibitor pyrrolidine dithio-carbamate
(PDTC) completely abolished secretions of IL-1b and IL-6 induced by
TNF-a. Data were mean ± SEM of six independent experiments. ∗P
< 0.05 compared to the cells treated with TNF-a and 0.5% fetal calf
serum (FCS) without LXA4 or PDTC. #P < 0.05 compared to the cells
treated with 0.5% FCS alone.
Figure 3. The marked increases in IL-1b and IL-6 pro-
tein synthesis evoked by TNF-a were down-regulated by
LXA4 at the concentration of 1 and 10 nmol/L. Pretreat-
ment of the cells with NF-jB inhibitor PDTC completely
abolished TNF-a–induced IL-1b and IL-6 productions.
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Fig. 4. Semiquantitative analysis using UVP-gel densitometry (A) of
electrophoresis of reverse transcription-polymerase chain reaction (RT-
PCR) products from cyclin E mRNA (B) in rat mesangial cells. Cultured
and serum-restricted glomerular mesangial cells were treated with tu-
mor necrosis factor-a (TNF-a) (10 ng/mL) for 12 hours, with or without
preincubation with lipoxin A4 (LXA4) at the indicated concentrations.
(B) is representative of four independent experiments, the lower panel
shows RT-PCR products from b-actin served as an internal control.
In (A), arbitrary unit (AU) = (AcyclinE/Ab−actin) × 100%. Data were
mean ± SEM of four independent experiments. ∗P < 0.05 compared to
the cells treated with TNF-a and 0.5% fetal calf serum (FCS) without
LXA4. #P < 0.05 compared to the cells treated with 0.5% FCS alone.
Effect of LXA4 on TNF-a–triggered cyclin E expression
As shown in Figures 4 and 5, the marked inductions
of cyclin E mRNA and protein expression were found in
parallel with proliferation of mesangial cells after stim-
ulation of the cells with TNF-a. These increments can
be inhibited by LXA4 at the concentration of 1 and 10
nmol/L. LXA4 at the concentration of 0.1 nmol/L had
no significant role on TNF-a–stimulated expressions of
cyclin E protein and mRNA.
Effect of LXA4 on TNF-a–induced alteration of AKT1
and p27kipl
In preliminary experiment, we performed time course
of TNF-a–induced Akt1 phosphorylation from 0 to
60 minutes, the phosphorylation peaked at 15 minutes,
similar to the time course of PDGF-induced Akt1 phos-
phorylation [33]. Thus, mesangial cells were exposed to
TNF-a for 15 minutes for measurement of Akt1. The
results of Western blotting analysis of phosphorylated
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Fig. 5. Semiquantitative analysis using UVP-gel densitometry (A) of
electrophoresis of Western blotting for cyclin E protein (B) in rat mesan-
gial cells. Cultured and growth-arrested glomerular mesangial cells were
treated with tumor necrosis factor-a (TNF-a) (10 ng/mL) for 24 hours,
with or without preincubation with lipoxin A4 (LXA4) at the indicated
concentrations. (B) is representative of four independent experiments,
the lower panel shows Western blotting of b-actin protein serving as
a loading control. In (A), arbitrary unit (AU) = (AcyclinE/Ab−actin) ×
100%. Data were mean ± SEM of four independent experiments. ∗P
< 0.05 compared to the cells treated with TNF-a and 0.5% fetal calf
serum (FCS) without LXA4. #P < 0.05 compared to the cells treated
with 0.5% FCS alone.
Akt1 (Thr308) are shown in Figure 6. Threonine phospho-
rylated Akt1 proteins at 308 site stimulated by TNF-a
were significantly reduced by LXA4 in a dose-dependent
manner. There was high expression of p27kipl protein in
controlled growth-arrested mesangial cells as shown in
Figure 7. TNF-a down-regulated the expression of p27kipl
protein in parallel with proliferation of mesangial cells.
However, TNF-a–induced decrement in expression of
p27kip1 protein was ameliorated by LXA4 at the dose
of 1 and 10 nmol/L. It was found that Akt1 and p27kipl
proteins changed in opposite directions when the cells
were exposed to TNF-a with or without pretreatment
with LXA4.
Effect of LXA4 on TNF-a–evoked activity of STAT3
The results of EMSA of STAT3 activity are shown
in Figure 8. Stimulation of mesangial cells with TNF-
a resulted in increment of DNA binding activity of
STAT3. This increment was abrogated by LXA4 in a
dose-dependent manner. Pretreatment of cells with low
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Fig. 6. Semiquantitative analysis using UVP-gel densitometry (A) of
electrophoresis of Western blotting for phosphorylated Akt1 (P-Akt1)
protein (B) in rat mesangial cells. Cultured and serum-starved glomeru-
lar mesangial cells were treated with tumor necrosis factor-a (TNF-a)
(10 ng/mL) for 15 minutes, with or without preincubation with lipoxin
A4 (LXA4) at the indicated concentrations. (B) is representative of four
independent experiments, the lower panel shows Western blotting of b-
actin protein serving as a loading control. In (A), arbitrary unit (AU) =
(AAkt1/Ab−actin) × 100%. Data were mean ± SEM of four independent
experiments. ∗P < 0.05 compared to the cells treated with TNF-a and
0.5% fetal calf serum (FCS) without LXA4. #P < 0.05 compared to the
cells treated with 0.5% FCS alone.
concentration of LXA4 (0.1 nmol/L) did not affect the
TNF-a–induced activity of STAT3.
Effect of LXA4 on TNF-a–activated of SHP-2/NF-jB
The results of immunoblotting analysis of phospho-
rylated SHP-2 are shown in Figure 9. SHP-2 tyrosine
phosphorylation stimulated by TNF-a was significantly
reduced by LXA4 at the dose of 1 and 10 nmol/L as com-
pared with the cells treated with TNF-a alone. Figure 10
shows the results of EMSA of NF-jB. Pretreatment of
cells with NF-jB inhibitor PDTC completely abolished
TNF-a–induced increment of DNA binding activities of
NF-jB. LXA4 at the dose of 1 and 10 nmol/L inhibited the
TNF-a–stimulated NF-jB activity. Figure 10C shows the
specification of TNF-a–induced NF-jB activity demon-
strated by gel supershift assay.
DISCUSSION
In these studies, we identified the inhibitory effects
of LXA4 on TNF-a–stimulated productions of IL-1b
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Fig. 7. Semiquantitative analysis using UVP-gel densitometry (A) of
electrophoresis of Western blotting for p27kipl protein (B) in rat mesan-
gial cells. Cultured and quiescent glomerular mesangial cells were
treated with tumor necrosis factor-a (TNF-a) (10 ng/mL) for 24 hours,
with or without preincubation with lipoxin A4 (LXA4) at the indicated
concentrations. (B) is representative of four independent experiments,
the lower panel shows Western blotting of b-actin protein serving as
a loading control. In (A), arbitrary unit (AU) = (Ap27kip1/Ab−actin) ×
100%. Data were mean ± SEM of four independent experiments. ∗P
< 0.05 compared to the cells treated with TNF-a and 0.5% fetal calf
serum (FCS) without LXA4. #P < 0.05 compared to the cells treated
with 0.5% FCS alone.
and IL-6 (Figs. 2 and 3) and proliferation of glomeru-
lar mesangial cells (Fig. 1). It is well known that TNF-a
plays a proinflammatory role on mesangial cells in patho-
genesis of glomerular inflammation [15, 16]. However,
there is no consensus concerning the mitogenic activ-
ity of TNF-a in cultured mesangial cells. DNA synthesis
was mostly reported to increase when murine, rat, or hu-
man mesangial cells cultured in non-FCS–supplemented
medium with TNF-a [16–19, 35], but rat mesangial cells
cultured in FCS-supplemented medium with TNF-a fail
to respond [36] or exhibit proliferation inhibition [34, 37].
In the presence of PDGF, TNF-a enhanced prolifera-
tion of growth-arrested human mesangial cells but TNF-a
alone did not affect the rate of proliferation of mesangial
cells [38]. These conflicting results may be attributable to
differences in culture conditions and the dose of TNF-
a. High dose of TNF-a or treatment with TNF-a for a
long time may cause apoptosis and growth inhibition of
cells [19, 32]. TNF-a stimulation induced dose-dependent
DNA synthesis in serum-starved human mesangial cells
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Fig. 8. Semiquantitative analysis using UVP-gel densitometry (A) of
electrophroretic mobility shift assay (EMSA) for activated signal tran-
ducers and activators of transcription (STAT3) (B) in rat mesangial
cells. Cultured and serum-deprived glomerular mesangial cells were
treated with tumor necrosis factor-a (TNF-a) (10 ng/mL) for 1 hour,
with or without preincubation with lipoxin A4 (LXA4) at the indicated
concentrations. Thirty micrograms of nuclear protein extracts were pre-
pared for detection of STAT3 activity by EMSA with c-[32P]-labeled
double-stranded oligonucleotide probe of STAT3. In (B),the upper ar-
row denotes the specific STAT3-DNA complexes. In (A), arbitrary unit
(AU) = (ATNF−a or ALXA4 or ATNF−a+LXA4/A0.5%FCS) × 100%. Data
were mean ± SEM of four independent experiments. ∗P < 0.05 com-
pared to the cells treated with TNF-a and 0.5% fetal calf serum (FCS)
without LXA4. #P < 0.05 compared to the cells treated with 0.5% FCS
alone.
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Fig. 9. Semiquantitative analysis using UVP-gel densitometry (A) of
immunoprecipiation and immunoblotting analysis for phosphorylated
Src homology 2 containing protein-tyrosine phosphatase (SHP-2) (B)
in mesangial cells. Cultured and serum-starved glomerular mesangial
cells were treated with tumor necrosis factor-a (TNF-a) (10 ng/mL)
for 30 minutes, with or without preincubation with lipoxin A4 (LXA4)
at the indicated concentrations. Whole-cell extracts (500 lg) were im-
munoprecipitated with 1 lg of antiphosphotyrosine antibody PY20,
and immunoprecipitates were resolved by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and analyzed by im-
munoblotting with anti-SHP-2 antibody. In (B), the lower panel shows
immunoblotting analysis of b-actin protein serving as a loading control.
In (A), arbitrary unit (AU) = (ASHP−2/Ab−actin) × 100%. Data were
mean ± SEM of four independent experiments. ∗P < 0.05 compared to
the cells treated with TNF-a and 0.5% fetal calf serum (FCS) without
LXA4. #P < 0.05 compared to the cells treated with 0.5% FCS alone.
to concentration of 33 ng/mL, but when stimulated with
170 ng/mL of TNF-a, DNA synthesis of the cells was de-
creased [19]. TNF-a at the dose of 10 or 100 ng/mL did
not increase the rate of apoptosis of cells after the growth-
arrested rat mesangial cells were exposed to TNF-a for
24 hours, but increased the rate of apoptosis of the cells
after the cells were exposed to TNF-a for 48 hours [32]. In
the current studies based on above reports and pilot ex-
periment using trypan blue exclusion assay which showed
the percentage of viable cells was more than 95% after
exposure to 10 ng/mL of TNF-a for 24 hours, the cells
were therefore treated with 10 ng/mL of TNF-a.
The anti-inflammatory and antimitogenic effects of
LXA4 were concentration-dependent. Different type of
cells may hold differences in response to LXA4. LXA4
at concentrations of 1 to 100 nmol/L inhibited TNF-a–
stimulated superoxide anion generation and IL-1b re-
lease by human neutrophils in a dose-dependent manner,
and LXA4 analogue at 10 nmol/L to 1 lmol/L also down-
regulated TNF-a–triggered IL-1b gene expression in a
dose-dependent manner in human neutrophils [8]. LXA4
at 10 pmol/L to 10 nmol/L inhibited IL-1b–induced re-
lease of IL-6, IL-8, and MMP-3 in synovial fibroblasts
[11]. Recently, Mitchell et al [39] showed that LXA4 at
the concentrations of 1 nmol/L to 1 lmol/L significantly
inhibited mitogenesis induced by PDGF in quiescent
mesangial cells in a dose-dependent manner. The present
study employed LXA4 at doses of 0.1 to 10 nmol/L. How-
ever, LXA4 at dose of 0.1 nmol/L had no significant mod-
ulatory role on synthesis of IL-1b and IL-6, cell growth,
expressions of cyclin E, Akt1, p27kip1, SHP-2, NF-jB,
and STAT3 stimulated by TNF-a in rat mesangial cells
(Figs. 1 to 10).
In the present studies, we investigated the effects of
LXA4 on levels of cell cycle proteins activated by TNF-
a. We demonstrated that the expressions of cyclin E and
threonine phosphorylated Akt1 protein at 308 site stimu-
lated by TNF-a can be down-regulated by LXA4 (Figs. 4
to 6), and TNF-a–induced decrement of p27kip1 can be at-
tenuated by LXA4 (Fig. 7). Akt phosphorylates p27kip1 at
Thr187, and promotes p27kip1 binding to Skp2 and p27kip1
destabilization. Akt also promotes 14-3-3 protein bind-
ing to p27kip1 by phosphorylation at Thr198, allowing its
cytoplasmic localization and degradation, removing its
repression on cyclin E/CDK2 activity, whereas Akt phos-
phorylation at Thr308 and Ser473 is necessary for full
activation of Akt and the subsequent regulation of
many biologic responses such as p27kip1 phosphorylation
[23, 25]. The current study therefore assessed alteration
of threonine phosphorylated Akt1 protein at 308 site
(Fig. 6). Our data showed that mesangial cell proliferation
stimulated by TNF-a was in parallel with increased phos-
phorylated Akt1 protein at Thr308 and cyclin E, down-
regulation of p27kip1 protein (Figs. 4 to 7), suggesting that
TNF-a–triggered activation of Akt induced p27kip1 phos-
phorylation and destabilization, a dissociation of p27kip1
from the cyclin E/CDK2 complex, which allowed cyclin
E/CDK2 activity to cause mesangial cells to enter into
S phase of the cell cycle. As shown in present studies,
LXA4 blocked the activation of Akt1 (Fig. 6) and decre-
ment of p27kip1 (Fig. 7), down-regulated the expression
of cyclin E (Figs. 4 and 5) evoked by TNF-a, suggest-
ing that LXA4 inhibited Akt1 phosphorylation at Thr308
and its activities, which may result in the reduced phos-
phorylation of p27kipl at Thr187 and Thr198 and decreased
degradation of p27kipl, the increased activity of p27kipl
could cause G1 arrest by inhibiting the activities of cy-
clin E/CDK2 complex (Figs. 4 and 5) and subsequent
proliferation of mesangial cells (Fig. 1). Our data pro-
vided the first evidence that LXA4 antagonized the TNF-
a–induced proliferation of mesangial cells through the
mechanisms of Akt1/p27kip1 pathway-dependent signal
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Fig. 10. Semiquantitative analysis using UVP-gel densitometry (A)
of electrophroretic mobility shift assay (EMSA) for activated nuclear
factor-jB (NF-jB) (B) in rat mesangial cells. Gel supershift assay (C)
demonstrated the specialty of activation of NF-jB by tumor necrosis
factor-a (TNF-a). Cultured and growth-arrested glomerular mesangial
cells were treated with TNF-a (10 ng/mL) for 1 hour, with or with-
out preincubation with lipoxin A4 (LXA4) at the indicated concen-
trations. Thirty micrograms of nuclear protein extracts were prepared
for detection of NF-jB activity by EMSA with c-[32P]-labeled double-
stranded oligonucleotide probe of NF-jB. In (B), the upper arrow de-
notes the specific NF-jB-DNA complexes. In (A), arbitrary unit (AU)
= (ATNF−a or ALXA4 or ATNF−a+LXA4 or ATNF−a+PDTC/A0.5%FCS) ×
100%. Data were mean ± SEM of four independent experiments. ∗P <
0.05 compared to the cells treated with TNF-a and 0.5% fetal calf serum
(FCS) without LXA4 and pyrrolidine dithio-carbamate (PDTC). #P <
0.05 compared to the cells treated with 0.5% FCS alone.
NF-κB
Supershift
Free
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C
Anti-p50 − + − − + −
Anti-p65 − − + − − +
TNF-a (10 ng/mL) + + + − − −
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Fig. 10. (continued)
transduction. These observations were consistent with
recent investigation of Mitchell et al [39], who demon-
strated LXA4 blocked PDGF-induced formation of cy-
clin E/CDK2 complex, Akt phosphorylation at Ser473 and
decrements of p21cip1, p27kip1 activity [39].
In the present studies, we also investigated the DNA
binding activity of STAT3 of the cells following TNF-a
stimulation. Our data indicated that TNF-a up-regulated
STAT3 activity in parallel with proliferation of mesangial
cells as delayed bands appeared on polyacrylamide gels
in EMSA due to combination of activated STAT3 with
labeled DNA probe (Fig. 8). However, this enhanced
STAT3 transcription activity can be inhibited by prein-
cubation of the cells with LXA4 in parallel with the
reduced proliferation of mesangial cells (Fig. 1), suggest-
ing that inhibitory effects of LXA4 on mitogenic role of
TNF-a in mesangial cells in present studies were me-
diated by blockage of JAK1/STAT3 signal pathway. In-
terestingly, these results were supported by investigation
of Leonard et al [14], who demonstrated that in experi-
mental ischemic acute renal failure, LXA4 analogue in-
creased renal mRNA levels of suppressors of cytokine
signaling-1 (SOCS-1) and SOCS-2, which were endoge-
nous inhibitors of JAK/STAT signaling pathways.
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NF-jB plays a pivotal role in mesangial cell activation
following TNF-a stimulation [26]. In the current studies,
our results presented evidence that enhanced expression
of IL-1b and IL-6 mRNA (Fig. 2) and synthesis of IL-1b
and IL-6 protein (Fig. 3) stimulated by TNF-a were me-
diated by activation of NF-jB, since preincubation of the
cells with NF-jB inhibitor PDTC completely abolished
both TNF-a–induced increment of DNA binding activity
of NF-jB (Fig. 10) and release of IL-1b and IL-6 protein
(Fig. 3). SHP-2 is an integral component of the IKK com-
plex and plays a positive role in mediating the induction
of NF-jB activity and IL-6 synthesis by TNF-a [30]. As
shown in Figures 9 and 10, LXA4 inhibited the activities of
SHP-2 and NF-jB induced by TNF-a, suggesting LXA4
down-regulated NF-jB by antagonism activation of SHP-
2-IKK complex. SHP-2 may have dual function in growth
factor and cytokine signaling pathway [40]. In some cases,
SHP-2 does play a negative role in intracellular signaling
transduction. For instance, SHP-2 functions as a nega-
tive regulator of the interferon-stimulated STAT1 and
STAT2 activation [41]. However, in most circumstances,
SHP-2 promotes activity of mitogenic signaling pathway
[40]. Angiotensin II activated both SHP-2 and JAK/STAT
pathway in mesangial cells [42]. Treatment of liver in vivo
with TNF-a markedly enhanced expression of SHP-2 and
STAT1 protein and association of SHP-2 with JAK1 [43].
In the present studies, treatment of mesangial cells with
TNF-a increased both STAT3 and SHP-2 activity (Figs. 8
and 9), and these increments can be inhibited by LXA4,
implicating SHP-2 may be also involved in STAT3 signal-
ing modulated by LXA4.
CONCLUSION
Our studies demonstrated that TNF-a–induced cell
proliferation and expression of cyclin E in rat mesan-
gial cells can be inhibited by LXA4, and this inhibitory
effect might be through the mechanism of STAT3 and
Akt1/p27kip1 pathway–dependent signal transduction.
LXA4 also antagonized TNF-a–stimulated IL-1b and IL-
6 synthesis, and this antagonism was related to SHP-2 and
NF-jB pathway–dependent signal transduction. These
data further expand on the anti-inflammatory and ant-
proliferative repertoire of lipoxins which represent useful
tools for the development of a new therapy in treatment
of glomerulonephritis [44].
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